Paper · 18436014
The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer.
Smith RA and 10 others. Surgery, 2008. Cited by 89 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Papers, record 18436014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18436014
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CA-19-9 Antigen | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Common Bile Duct Neoplasms | Major topic |
| Pancreatic Neoplasms | Major topic |
| Aged | |
| Female | |
| Humans | |
| Laparoscopy | |
| Lymphocyte Count | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Patient Selection | |
| Platelet Count |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Cancer Research UK | United Kingdom | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,580,763 | Haematological Inflammatory Indices in Preschoolers With Developmental Language Disorder: The Role of the Systemic Inflammation Response Index. | Int J Dev Neurosci | 2026 | https://conductscience.org/library/papers/42580763 | PubMed |
| 41,377,914 | Associations of novel blood-derived markers of inflammation with blood pressure, arterial stiffness and heart rate in young adults. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41377914 | PubMed |
| 41,301,018 | Evaluating the Role of Morphological Subtypes in the Classification of Periampullary Adenocarcinomas. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41301018 | PubMed |
| 41,029,097 | V-shaped relationship between platelet-to-lymphocyte ratio and mortality in patients with cardio-cerebrovascular disease: An observational study. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41029097 | PubMed |
| 39,726,408 | The Serum Biomarkers in Ulcerative Colitis. | Medeni Med J | 2024 | https://conductscience.org/library/papers/39726408 | PubMed |
| 39,464,342 | Application Value of Platelet-to-Lymphocyte Ratio as a Novel Indicator in Rheumatoid Arthritis: A Review Based on Clinical Evidence. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39464342 | PubMed |
| 39,052,624 | Association between SII and markers of liver injury: A cross-sectional study from the NHANES (2017-2020). | PLoS One | 2024 | https://conductscience.org/library/papers/39052624 | PubMed |
| 38,549,089 | The impact of preoperative biliary drainage on postoperative healthcare-associated infections and clinical outcomes following pancreaticoduodenectomy: a ten-year retrospective analysis. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/38549089 | PubMed |
| 38,343,523 | Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. | Turk J Emerg Med | 2024 | https://conductscience.org/library/papers/38343523 | PubMed |
| 37,809,135 | Significance of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Preoperative Nutritional Index as Predictors of Morbidity in Patients Who Underwent Liver Resection for Alveolar Echinococcosis. | Cureus | 2023 | https://conductscience.org/library/papers/37809135 | PubMed |
1 to 10 of 52
See all 52 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18436014
GET https://conductscience.org/api/papers/v1/18436014/cited_by?page=2